STOM and breast carcinoma: Compatible with a previous immunohistochemistry study, which showed that 31 % of the breast cancers were negative and 39 % weak for stomatin staining, the overall immunohistochemistry staining in our study showed negative staining in 47 % (32/68) of samples and positive staining in 53 % (36/68) of samples.